Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neuro-Cognitive Correlates of Pediatric Anxiety Disorders
NCT00018057Phase 2Recruiting
- Sponsor
- National Institute of Mental Health
- Start
- Oct 2001
- Primary completion
- Jan 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of fluoxetine in anxiety disorder (2 arms), sponsored by National Institute of Mental Health. Primary endpoints: Indices of percent-signal change in hypothesized brain regions, Pediatric Anxiety Rating Scale and 1 more. Started Oct 2001; status: recruiting.
02
Drugs
fluoxetine
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT00018057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00018057.